Skip to Main Content

Author Details

Sharon N Teraoka
1996
29
19
PMIDPaper TitleJournal TitlePublished Year
34153142Genes affecting ionizing radiation survival identified through combined exome sequencing and functional screening.Hum Mutat2021
32119081Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.J Natl Cancer Inst2020
29029884Identification of ATIC as a Novel Target for Chemoradiosensitization.Int J Radiat Oncol Biol Phys2018
24651433Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks.Cell Death Dis2014
23706288Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Eur J Cancer2013
23775025Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.Cancer Causes and Control2013
23565321Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.International Journal of Molecular Epidemiology and Genetics (discontinued)2013
23269995Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.J Clin Oncol2013
21898661Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.Hum Mutat2012
23033454Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.Cancer Epidemiology Biomarkers and Prevention2012
22087758Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.Breast Cancer Res2011
21161372Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.Breast Cancer Res Treat2011
21520273Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.Genetic Epidemiology2011
20368571Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.J Clin Oncol2010
19597986Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.Breast Cancer Res Treat2010
20135344Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.Breast Cancer Research and Treatment2010
20130978Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.Cancer Causes Control2010
20305132Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.J Natl Cancer Inst2010
20104584Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.Hum Mutat2010
18701470Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.Cancer Res2008
16492927The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry.Cancer Epidemiol Biomarkers Prev2006
16958054Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.Hum Mutat2006
16266405ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia.Annals of Human Genetics2005
14654357Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression.Molecular Genetics and Metabolism2003
12673797Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.Hum Mutat2003
11505391Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history.Cancer2001
10330348Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.Am J Hum Genet1999
9443866Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.Am J Hum Genet1998
8808599A high frequency of distinct ATM gene mutations in ataxia-telangiectasia.Am J Hum Genet1996
  • 1 - 29 of 29

Recommended Authors

Collaborators

Co-authored papers 29
Co-authored papers 20
Co-authored papers 18
Co-authored papers 18
Co-authored papers 17
Co-authored papers 16
Co-authored papers 11
Co-authored papers 10
Co-authored papers 9
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 6
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
University of Utah
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, 9609 Medical Center Dr
Co-authored papers 2
Co-authored papers 2
University of Toronto
Co-authored papers 2
University of Minnesota
Co-authored papers 2
University of California irvine
Co-authored papers 2
Co-authored papers 2
Istanbul Technical University
Co-authored papers 2
Co-authored papers 1